Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

69.46 -0.20 (-0.29%)
Official Closing Price Updated: 7:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,139,240
Open 69.35
Bid (Size) 69.04 (1)
Ask (Size) 69.90 (1)
Prev. Close 69.66
Today's Range 68.95 - 69.54
52wk Range 67.13 - 94.87
Shares Outstanding 607,900,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$1000 Invested In This Stock 15 Years Ago Would Be Worth $15,000 Today
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga

Performance

YTD
-6.48%
-6.48%
1 Month
-8.64%
-8.64%
3 Month
-22.38%
-22.38%
6 Month
-14.16%
-14.16%
1 Year
-16.90%
-16.90%

More News

Read More
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
Via Benzinga
Patients With Deadly Heart Disease Underdiagnosed, Including 66% of Women: AI-Powered Clinical Study Shows
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Expert Ratings for Edwards Lifesciences
Via Benzinga
Analyst Ratings for Edwards Lifesciences
Via Benzinga
(EW) - Analyzing Edwards Lifesciences's Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Via Benzinga
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
Via MarketBeat
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
Via Benzinga
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
Via InvestorPlace
Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing
Via Benzinga
eBay, Barclays, Edwards Lifesciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase
Via Investor's Business Daily
US Stock Futures Signal Shaky Open On Mixed Tech Earnings: Analyst Expects Fed To Adopt 'Wait-And-See' Rate Approach
Via Benzinga
Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.